Delivery Order SPE2DB25D3005-SPE2DB25FQDSA

Award Date 3/27/25
Potential Completion Date 3/28/25
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the delivery of XARELTO 10 MG tablets. The $3,736.63 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The contract has an ultimate completion date of October 24, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, which serves as a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of XARELTO 20 MG TABLET 90S. The contract has a ceiling value of $16,491.27 and a completion date of November 26, 2024. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,916.54 firm fixed-price delivery order is for XARELTO 20 MG TABLET 90S, with an ultimate completion date of April 3, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of XARELTO 20 MG TABLET 90S. The contract is a Firm Fixed Price Delivery Order valued at $96,970.77, with a completion date of December 16, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the delivery of XARELTO 20 MG TABLET 90S to the Defense Logistics Agency (DLA). The delivery order, valued at $10,205.61, was issued under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical. This IDC, worth up to $999,999,999, serves as a primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Firm Fixed Price Delivery Order worth $44,621.08 from the Defense Logistics Agency (DLA). The contract is for the supply of XARELTO 20 MG TABLET 90S, a prescription medication, to support military healthcare programs. The contract has an ultimate completion date of July 1, 2024 and was awarded on June 28, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of XARELTO 20 MG TABLET 90S. The contract has a ceiling value of $2,898.80 and an ultimate completion date of July 26, 2022. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen Drug Corp holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026....
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order valued at $16,675.74 that was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of XARELTO 20 MG TABLET 90S, a pharmaceutical product, with an ultimate completion date of August 2, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables DLA to efficiently...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of XARELTO 20 MG TABLET 90S. The contract is a Delivery Order with a Firm Fixed Price of $12,413.04 and a period of performance through April 1, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of XARELTO 20 MG TABLET 90S. The $3,476.07 Firm Fixed Price Delivery Order contract has an ultimate completion date of April 20, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
  • SPE2DB25D3005
    Indefinite Delivery Contract
  • SPE2DB25D3005-SPE2DB25FQDSA
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of XARELTO 20 MG TABLET 90S. The contract has a firm fixed price of $15,164.74 and an ultimate completion date of March 28, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.

Generated 6/26/25, 9:52 AM